In a report released today, Serge Belanger from Needham maintained a Hold rating on Amphastar Pharmaceuticals (AMPH – Research Report). The company's shares closed last Friday at $40.39. According to TipRanks.com, Belanger is a 4-star analyst with an average return of 9.1% and a 50.0% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Clarus Therapeutics Holdings, Collegium Pharmaceutical, and KalVista Pharmaceuticals. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Amphastar Pharmaceuticals with a $33.25 average price target. See today’s best-performing stocks on TipRanks >> The company has a one-year high of $40.36 and a one-year low of $16.91.
https://www.tipranks.com/news/blurbs/amphastar-pharmaceuticals-amph-gets-a-hold-rating-from-needham?utm_source=advfn.com&utm_medium=referral
Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Amphastar Pharmaceuticals Charts.
Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Amphastar Pharmaceuticals Charts.